Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


1 Ann Oncol
3 Br J Cancer
6 Gynecol Oncol
1 Obstet Gynecol
1 Oncol Rep
1 PLoS One
2 Tumour Biol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Oncol

  1. RONCOLATO FT, Gibbs E, Lee CK, Asher R, et al
    Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy.
    Ann Oncol. 2017 Jun 8. doi: 10.1093.
    PubMed     Text format     Abstract available

    Br J Cancer

  2. BANDERA EV, Lee VS, Qin B, Rodriguez-Rodriguez L, et al
    Impact of body mass index on ovarian cancer survival varies by stage.
    Br J Cancer. 2017 Jun 6. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  3. BEGG CB, Rice MS, Zabor EC, Tworoger SS, et al
    Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries.
    Br J Cancer. 2017 Mar 23. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  4. HEUDEL PE, Fabbro M, Roemer-Becuwe C, Kaminsky MC, et al
    Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
    Br J Cancer. 2017 Jan 10. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  5. XIONG J, He M, Hansen K, Jackson CL, et al
    The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma.
    Gynecol Oncol. 2016 May 3. pii: S0090-8258(16)30679.
    PubMed     Text format     Abstract available

  6. KARLSEN NM, Karlsen MA, Hogdall E, Nedergaard L, et al
    Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).
    Gynecol Oncol. 2016 May 7. pii: S0090-8258(16)30684.
    PubMed     Text format     Abstract available

  7. DAI D, Thiel KW, Salinas EA, Goodheart MJ, et al
    Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.
    Gynecol Oncol. 2016 May 16. pii: S0090-8258(16)30731.
    PubMed     Text format     Abstract available

  8. SCHLAPPE BA, Mueller JJ, Zivanovic O, Gardner GJ, et al
    Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.
    Gynecol Oncol. 2016 May 14. pii: S0090-8258(16)30734.
    PubMed     Text format     Abstract available

  9. DILLEY SE, Havrilesky LJ, Bakkum-Gamez J, Cohn DE, et al
    Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
    Gynecol Oncol. 2017 May 31. pii: S0090-8258(17)30890.
    PubMed     Text format     Abstract available

  10. VOGEL TJ, Goodman MT, Li AJ, Jeon CY, et al
    Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
    Gynecol Oncol. 2017 Jun 5. pii: S0090-8258(17)30848.
    PubMed     Text format     Abstract available

    Obstet Gynecol

  11. MELAMED A, Rizzo AE, Nitecki R, Gockley AA, et al
    All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002102.
    PubMed     Text format     Abstract available

    Oncol Rep

  12. CHEN X, Ying X, Wang X, Wu X, et al
    Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization.
    Oncol Rep. 2017 Jun 6. doi: 10.3892/or.2017.5697.
    PubMed     Text format     Abstract available

    PLoS One

  13. STAFFORD JL, Dyson G, Levin NK, Chaudhry S, et al
    Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.
    PLoS One. 2017;12:e0178450.
    PubMed     Text format     Abstract available

    Tumour Biol

  14. SU YK, Huang WC, Lee WH, Bamodu OA, et al
    Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication.
    Tumour Biol. 2017;39:1010428317691689.
    PubMed     Text format     Abstract available

  15. GASPARRI ML, Casorelli A, Bardhi E, Besharat AR, et al
    Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer.
    Tumour Biol. 2017;39:1010428317695525.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.